MYL3 and hypertrophic cardiomyopathy: However, Ma et al. recently demonstrated in iPSC-derived cardiomyocyte models carrying the MYL3 c.170C>A variant that this mutation failed to elicit classic hypertrophic cardiomyopathy (HCM) phenotypes, suggesting it may be a benign variant [111].